Literature DB >> 13042575

Time-dosage relation in penicillin therapy with special reference to yaws. II. Clinical basis for effective therapy.

C R REIN, D K KITCHEN.   

Abstract

Entities:  

Keywords:  PENICILLIN/therapeutic use; YAWS/therapy

Mesh:

Substances:

Year:  1953        PMID: 13042575      PMCID: PMC2554285     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  9 in total

1.  A study of cross immunity between syphilis and yaws in treated rabbits.

Authors:  C P McLEOD; H J MAGNUSON
Journal:  J Vener Dis Inf       Date:  1951-11

2.  Penicillin therapy of yaws and serologic results.

Authors:  C R REIN; T H STERNBERG
Journal:  Arch Derm Syphilol       Date:  1948-06

3.  Penicillin Treatment of Early Syphilis-A Preliminary Report.

Authors:  J F Mahoney; R C Arnold; A Harris
Journal:  Am J Public Health Nations Health       Date:  1943-12

4.  Serum concentrations following five treatment schedules with procaine penicillin in oil with aluminum monostearate.

Authors:  D K KITCHEN; E W THOMAS; C R REIN
Journal:  J Invest Dermatol       Date:  1949-02       Impact factor: 8.551

5.  Treatment of yaws in the Haitian peasant.

Authors:  C R REIN
Journal:  J Natl Med Assoc       Date:  1949-03       Impact factor: 1.798

6.  Reactions to penicillin.

Authors:  D K KITCHEN; C R REIN; E W THOMAS; H J SPOOR
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1951-11

7.  Aureomycin in the treatment of yaws.

Authors:  E H LOUGHLIN; A JOSEPH; K SCHAEFFER
Journal:  Am J Trop Med Hyg       Date:  1951-01       Impact factor: 2.345

8.  Penicillin treatment of syphilis.

Authors:  A C CURTIS; D K KITCHEN; P A O'LEARY; H RATTNER; C R REIN; A G SCHOCH; L W SHAFFER; U J WILE
Journal:  J Am Med Assoc       Date:  1951-04-21

9.  Immobilization of Treponema pallidum in vitro by antibody produced in syphilitic infection.

Authors:  R A NELSON; M M MAYER
Journal:  J Exp Med       Date:  1949-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.